Study shows specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

LifeCare Alliance and the Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Center and Richard J. Solove Research Institute announced a partnership aimed at enhancing access to breast cancer screening and diagnostics for underserved individuals across Ohio.

August 02, 2024

Vol.50 No.31

Clinical Roundup

Electronic prompt for surgeons may reduce breast cancer overtreatment

University of Pittsburgh and UPMC Hillman Cancer Center researchers have developed a novel prompt, or ‘nudge,’ embedded in the electronic health record that flags, for treating surgeons, older patients with early-stage breast cancer who may be at risk for unnecessary lymph node surgery.

July 19, 2024

Vol.50 No.29

In Brief

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Mark Burkard was named director of University of Iowa Health Care Holden Comprehensive Cancer Center.

July 12, 2024

Vol.50 No.28

Clinical Roundup

Chemotherapy disrupts gut microbiome in patients with breast cancer

Chemotherapy is known to cause behavioral side effects, including cognitive decline. Notably, the gut microbiome communicates with the brain to affect behavior, including cognition.

July 12, 2024

Vol.50 No.28

In Brief

UAMS Winthrop P. Rockefeller Cancer Institute receives five NCI grants

Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences have been awarded five grants from NCI in 2024, totaling $4.6 million.

June 28, 2024

Vol.50 No.26

Clinical Roundup

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Both Tai Chi and cognitive behavioral therapy can reduce insomnia in breast cancer survivors but also may provide additional health benefits by reducing inflammation and bolstering anti-viral defenses, according to a study led by UCLA Health researchers. The work was published in Brain, Behavior, and Immunity.

June 28, 2024

Vol.50 No.26

Study shows specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life

YOU MAY BE INTERESTED IN

LifeCare Alliance, Ohio State collaborate to advance cancer health equity

Electronic prompt for surgeons may reduce breast cancer overtreatment

Mark Burkard named director of UI Health Care Holden Comprehensive Cancer Center

Chemotherapy disrupts gut microbiome in patients with breast cancer

UAMS Winthrop P. Rockefeller Cancer Institute receives five NCI grants

Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors

Renew today!

Subscriber content

Login